Nov. 10-12, 2016

AMP 2016 Annual Meeting

Association Molecular Pathology Annual Meeting in Charlotte, NC, Nov. 10-12, 2016. Booth 826, 828
June 16-20, 2016

ASM/ICAAC, 2016

American Society for Microbiology, Boston, MA, June 16-20, 2016, Booth 623
January 11, 2016

QuanDx Raises $3.0 Million in Series B2 Financing

San Jose, CA, USA. Jan. 11, 2016 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, today announced that […]
June 15-18, 2016

EUROGIN( EUropean Research Organisation on Genital Infection and Neoplasia),2016

Salzburg, Austria, June 15-18,2016, Booth 7
June 3-7

ASCO

Chicago, IL, June 3-7, Booth 25088
May 19-22, 2016

Clinical Virology Symposium (CVS), 2016

Daytona Beach, FL, May 19-22, 2016, Booth 438
April 9-12

ECCMID, 2016

Amsterdam, Netherland, April 9-12
March 6-11, 2016

Molecular Med Tri-Con Main Conf. 2016

San Francisco, CA, March 6-11, 2016, Booth 632
November 24, 2015

QuanDx Announces Distribution Agreement for the Zeesan CE-IVD High Risk HPV Genotyping Assay

San Francisco, CA, USA. Nov. 24, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, today announced that […]
September 24, 2015

See you at AMP annual meeting in Austin, TX

San Francisco, CA, USA. Sept. 24th, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, welcome you to […]